Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | THPO | P40225 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.33 |
| ▸ | RELA | Q04206 | 1/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | LTA4H | P09960 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | MTOR | P42345 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2927823 | 1.00 | APP (0.39) | APPNPSR1TSHRTP53CYP1A2 | |
| SCHEMBL496614 | 1.00 | APP (0.39) | APPNPSR1TSHRTP53CYP1A2 | |
| SCHEMBL6158433 | 0.81 | APP (0.36) | APPNPSR1TSHRTP53CYP1A2 | |
| SCHEMBL1610832 | 0.81 | APP (0.36) | APPNPSR1TSHRTP53CYP1A2 | |
| SCHEMBL1611959 | 0.78 | ALDH1A1 (0.42) | NPSR1MAPTNPC1RAB9AKCNH2 | |
| SCHEMBL4960967 | 0.78 | LTA4H (0.38) | APPTSHRTP53CYP1A2CYP3A4 | |
| SCHEMBL1611004 | 0.78 | LTA4H (0.38) | APPTSHRTP53CYP1A2CYP3A4 | |
| SCHEMBL1610304 | 0.76 | CYP2A6 (0.52) | TSHRTP53CYP2C9MAPT | |
| SCHEMBL1610492 | 0.76 | LTA4H (0.39) | TSHRTP53CYP3A4LTA4H | |
| SCHEMBL7382992 | 0.76 | LTA4H (0.39) | TSHRTP53CYP3A4LTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1154 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9660195-B2 | Anthracene derivative having a phenanthryl group | IDEMITSU KOSAN CO., LTD. (JP) | 2017-05-23 | — | — | US | claimed |
| US-8822041-B2 | Anthracene derivatives, luminescent materials and organic electroluminescent devices | IDEMITSU KOSAN CO., LTD. (JP) | 2014-09-02 | — | — | US | claimed |
| US-20140103319-A1 | ANTHRACENE DERIVATIVES, LUMINESCENT MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICES | IDEMITSU KOSAN CO., LTD. (JP) | 2014-04-17 | — | — | US | claimed |
| EP-1653960-A4 | MELANIN CONCENTRATING HORMONE RECEPTOR ANTAGONIST | AMGEN INC (US) | 2008-11-26 | — | — | EP | claimed |
| EP-1654225-A4 | MELANIN CONCENTRATING HORMONE RECEPTOR ANTAGONISTS | AMGEN INC (US) | 2007-11-28 | — | — | EP | claimed |
| EP-1653960-A2 | MELANIN CONCENTRATING HORMONE RECEPTOR ANTAGONIST | AMGEN INC. (US) | 2006-05-10 | — | — | EP | claimed |
| EP-1654225-A2 | MELANIN CONCENTRATING HORMONE RECEPTOR ANTAGONISTS | Amgen, Inc. (US) | 2006-05-10 | — | — | EP | claimed |
| US-20050256161-A1 | Melanin concentrating hormone receptor antagonists | AMGEN INC. | 2005-11-17 | — | — | US | claimed |
| US-20050215526-A1 | Melanin concentrating hormone receptor antagonist | AMGEN, INC. | 2005-09-29 | — | — | US | claimed |
| WO-2005019167-A2 | MELANIN CONCENTRATING HORMONE RECEPTOR ANTAGONIST | AMGEN, INC. (US) | 2005-03-03 | — | — | WO | claimed |
| WO-2001037652-A2 | CARBAMOYL TRIAZOLINONE-BASED HERBICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2001-05-31 | — | — | WO | claimed |
| EP-0784431-B1 | SYNERGISTIC ACTIVE SUBSTANCE HERBICIDE COMBINATIONS WITH 1-(2,6-DICHLORO-4-DIFLUOROMETHYL-PHENYL)-5-(2-CHLOROPROPIONAMIDO)-4-NITROPYRAZOL | BAYER AG (DE) | 2000-03-08 | — | — | EP | claimed |
| US-5990044-A | Selective herbicides based on aryl uracils | BAYER AKTIENGESELLSCHAFT (DE) | 1999-11-23 | — | — | US | claimed |
| EP-0786938-A1 | SELECTIVE HERBICIDES BASED ON CARBAMOYLTRIAZOLINONES AND HETEROARYLOXYACETAMIDES | BAYER AG (DE) | 1997-08-06 | — | — | EP | claimed |
| EP-0778732-A1 | SELECTIVE HERBICIDES BASED ON ARYL URACILS | BAYER AG (DE) | 1997-06-18 | — | — | EP | claimed |
| EP-0319986-B1 | Anti-plasmin depressant | NIPPON SHINYAKU CO LTD (JP) | 1997-03-12 | — | — | EP | claimed |
| WO-1996011575-A1 | SELECTIVE HERBICIDES BASED ON CARBAMOYLTRIAZOLINONES AND HETEROARYLOXYACETAMIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1996-04-25 | — | — | WO | claimed |
| WO-1996007323-A1 | SELECTIVE HERBICIDES BASED ON ARYL URACILS | BAYER AKTIENGESELLSCHAFT (DE) | 1996-03-14 | — | — | WO | claimed |
| US-5276008-A | Herbicides and plant growth regulators | BAYER AKTIENGESELLSCHAFT (DE) | 1994-01-04 | — | — | US | claimed |
| US-4410730-A | Process for the production of o-(N-monosubstituted amino)benzyl alcohols | SHIONOGI & CO., LTD. (JP) | 1983-10-18 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050215526-A1 | Melanin concentrating hormone receptor antagonist | MCHR1, MC1R, NPY1R | APP 1503/4885NPSR1 35/4885TSHR 17/4885 |
| US-20050256161-A1 | Melanin concentrating hormone receptor antagonists | MCHR1, MC1R, NPY1R | APP 1715/4885NPSR1 27/4885TSHR 19/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.